Director Jeffrey Segal resigns from INVO Bioscience board, no disagreement

INVO Fertility, Inc.

Jeffrey Segal, MD resigned as director effective March 31, 2023.
Resignation not due to any disagreements with the company regarding operations, policies, or practices.
The company has not announced a replacement for the vacant board seat.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeffrey Segal

director

IVF · INVO Fertility, Inc.

Effective: 2023-03-31
Filed: April 4, 2023, 7:59 PM ET

On March 31, 2023, Jeffrey Segal MD submitted his resignation as a director of INVO Bioscience, Inc. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Segal resigned as director at INVO Fertility, Inc..

Action: resigned
Role: director

Exact text from the filing

On March 31, 2023, Jeffrey Segal MD submitted his resignation as a director of INVO Bioscience, Inc. (the “Company”).

View on SEC.gov

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-010813

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.